Back to Authors

Costanzi, Chiara

A5076175540 | I1330342723

Mayo Clinic

Department of Neurology Rochester MN United States

Citations 7

Central Dysregulation of Heart Rate and Blood Pressure in Autoimmune AQP4 Channelopathy: Expanding the neuromyelitis optica spectrum disorder (NMOSD). (S20.008)

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.s20.008

A Systematic Clinico-Serologic Study of Recurrent Longitudinally Extensive Transverse Myelitis (rTM) and Comparison with NMO (P02.141)

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p02.141

What Is the Frequency of “Truly” AQP4-IgG-Negative NMO and Does It Differ Phenotypically from Seropositive Disease? (P02.136)

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p02.136

Clinical–radiological–pathological spectrum of central nervous system–idiopathic inflammatory demyelinating disease in the elderly

Multiple Sclerosis Journal | October 19, 2016 | Volume: 23 | Issue: 9 | Pages: 1204-1213

10.1177/1352458516675748 | PMID 27760861

Background: The spectrum of central nervous system–idiopathic inflammatory demyelinating disease (CNS-IIDD) in the elderly is uncertain. Objective: To describe the clinical, radiological, and pathological features of a cohort of 30 pathologically proven CNS-IIDD patients ⩾65 years. Methods: Elderly multiple sclerosis (MS)/clinically isolated syndrome (CIS) patients were compared to a cohort of 125 patients with pathologically proven MS/CIS and symptom onset <65 years. Results: Median age at symptom onset was 69 years (interquartile range (IQR) = 68–75). Median follow-up was 1.9 years (IQR = 1.0–5.6). Diagnoses were MS (14/30), CIS (11/30), neuromyelitis optica (NMO; 4/30), and acute disseminated encephalomyelitis (ADEM; 1/30). Disability was higher in patients with MS/CIS ⩾65 compared to patients <65 (median Expanded Disability Status Scale (EDSS) 4 (IQR = 2.5–7) vs 2.5 (IQR = 1.5–4); p = 0.002). When compared to patients <65 years, there was no difference in the lesion size, number of patients fulfilling Barkhof’s criteria, edema, or mass effect. Confluent demyelination was observed in 27 patients (MS/CIS (23/25), NMO (4)), 2 had a mixed perivenular/confluent pattern (MS (1), ADEM (1)), and 1 patient with MS had a mixed confluent/perivenular/coalescent pattern. Early active lesions were found in 19/30 patients ((MS (4), CIS (13), NMO (2); 53%). Cortical demyelination was present in 7/12 (58%) patients (MS (3), CIS(3), ADEM (1)). Conclusion: A spectrum of CNS-IIDD can develop in the elderly, with presenting symptoms similar to younger patients. Early diagnosis of CNS demyelinating disease is essential to avoid invasive and disabling procedures.
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica

Neurology | August 30, 2013 | Volume: 81 | Issue: 14 | Pages: 1197-1204

10.1212/wnl.0b013e3182a6cb5c | PMID 23997151

Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica

Neurology | October 14, 2011 | Volume: 77 | Issue: 17 | Pages: 1644-1646

10.1212/wnl.0b013e3182343377 | PMID 21998320

Azathioprine

Neurology | August 4, 2011 | Volume: 77 | Issue: 7 | Pages: 659-666

10.1212/wnl.0b013e31822a2780 | PMID 21813788